US HB4475 | 2013-2014 | 113th Congress
Status
Sponsorship: Partisan Bill (Republican 5)
Status: Introduced on April 10 2014 - 25% progression, died in committee
Action: 2014-04-11 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 10 2014 - 25% progression, died in committee
Action: 2014-04-11 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Compassionate Freedom of Choice Act of 2014 - Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the manufacture, importation, distribution, or sale of investigational drugs or devices for terminally ill patients. Prohibits the FDA Commissioner from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA. Declares that, except in cases of gross negligence or willful misconduct, any person who manufactures, imports, distributes, prescribes, or administers an investigational drug or device shall not be liable in any action under state or federal law for loss, damage, or injury arising out of, relating to, or resulting from: (1) the design, development, clinical testing and investigation, manufacturing, labeling, distribution, sale, purchase, donation, dispensing, prescription, administration, or use of such drugs or devices; or (2) their safety or effectiveness.
Title
Compassionate Freedom of Choice Act of 2014
Sponsors
| Rep. Morgan Griffith [R-VA] | Rep. Ken Calvert [R-CA] | Rep. John Duncan [R-TN] | Rep. Richard Hanna [R-NY] |
| Rep. Matt Salmon [R-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2014-04-11 | House | Referred to the Subcommittee on Health. |
| 2014-04-10 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
HB5854 (Related) 2014-12-11 - Referred to the House Committee on Energy and Commerce.
Subjects
Business records
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health technology, devices, supplies
Long-term, rehabilitative, and terminal care
Prescription drugs
Retail and wholesale trades
Trade restrictions
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health technology, devices, supplies
Long-term, rehabilitative, and terminal care
Prescription drugs
Retail and wholesale trades
Trade restrictions
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/house-bill/4475/all-info |
| Text | https://www.congress.gov/113/bills/hr4475/BILLS-113hr4475ih.pdf |
